Montelukast Teva (Montelukast Sodium)

Montelukast blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotriene D4 from binding. This action stops leukotriene‑driven bronchoconstriction, mucus production, and inflammatory cell recruitment, leading to improved airway function and reduced allergic symptoms.

The appropriate dose of Montelukast Teva is determined by a qualified prescriber based on the patient’s age, condition, and clinical response. Healthcare professionals follow approved labeling and individual patient needs when selecting the dosage regimen.

Safety data for Montelukast in pregnancy are limited, so it should only be used if the potential benefit justifies the risk. During breastfeeding, the drug passes into milk in small amounts; clinicians should weigh benefits to the mother against possible effects on the infant.

To request Montelukast Teva, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. It is particularly useful for patients with aspirin‑sensitive asthma or those who prefer a once‑daily tablet, but it is generally used as add‑on therapy rather than a sole replacement for inhaled steroids.

Montelukast Teva tablets should be stored at temperatures below 25 °C, in their original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool environment helps maintain its potency throughout its shelf life.

Montelukast Teva is taken orally, usually as a single tablet once daily in the evening. The tablet should be swallowed whole with water and not chewed or crushed, unless the prescriber provides specific instructions for a different formulation.

Serious adverse events, though rare, include angioedema, severe allergic reactions, mood changes such as depression or suicidal thoughts, and hepatic enzyme elevations. Patients should seek immediate medical attention if they experience swelling of the face or throat, unexplained mood alterations, or signs of liver dysfunction.

Montelukast Teva is contraindicated in individuals with known hypersensitivity to montelukast or any of its excipients. Caution is advised for patients with severe hepatic impairment, and it should be avoided in those who have experienced serious allergic reactions to the drug in the past.